← Evidence map

ArticleJournal of neuro-oncology2018

Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab?

Enrico Franceschi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29671196